Daphne Dumoulin

Daphne Dumoulin is a Researcher at Erasmus MC in the Pulmonary Medicine department. Her work focuses on clinical oncology and pharmacology.

• Lung cancer therapies
• Immunotherapy optimization
• Pharmacokinetics in renal impairment
• Novel dosing regimens
• Pleural mesothelioma management

Her recent publications include studies on lurbinectedin in small cell lung cancer, TEIPP-vaccination in non-small cell lung cancer, and pembrolizumab dosing bioequivalence. She collaborates internationally on compassionate use programs and real-world treatment outcomes.

Her research integrates Oncology, Pharmacology, and Clinical Medicine, often employing multicenter cohort designs and phase I/II trials.

Key networks include collaborations with J.G.J.V. Aerts (Erasmus MC) and R.H.J. Mathijssen (Radboud University) across 44 total research outputs.